These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 33022955)

  • 1. Cognitive Outcomes and Relationships with Phenylalanine in Phenylketonuria: A Comparison between Italian and English Adult Samples.
    Romani C; Manti F; Nardecchia F; Valentini F; Fallarino N; Carducci C; De Leo S; MacDonald A; Palermo L; Leuzzi V
    Nutrients; 2020 Oct; 12(10):. PubMed ID: 33022955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emotional health in early-treated adults with phenylketonuria (PKU): Relationship with cognitive abilities and blood phenylalanine.
    Palermo L; MacDonald A; Limback E; Robertson L; Howe S; Geberhiwot T; Romani C
    J Clin Exp Neuropsychol; 2020 Mar; 42(2):142-159. PubMed ID: 31790339
    [No Abstract]   [Full Text] [Related]  

  • 3. Cognitive outcomes in early-treated adults with phenylketonuria (PKU): A comprehensive picture across domains.
    Palermo L; Geberhiwot T; MacDonald A; Limback E; Hall SK; Romani C
    Neuropsychology; 2017 Mar; 31(3):255-267. PubMed ID: 28080075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review of cognitive functioning in early treated adults with phenylketonuria.
    Hofman DL; Champ CL; Lawton CL; Henderson M; Dye L
    Orphanet J Rare Dis; 2018 Aug; 13(1):150. PubMed ID: 30165883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analyses of cognitive functions in early-treated adults with phenylketonuria.
    Romani C; Olson A; Aitkenhead L; Baker L; Patel D; Spronsen FV; MacDonald A; Wegberg AV; Huijbregts S
    Neurosci Biobehav Rev; 2022 Dec; 143():104925. PubMed ID: 36283539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of phenylalanine levels on cognitive outcomes in adults with phenylketonuria: Effects across tasks and developmental stages.
    Romani C; Palermo L; MacDonald A; Limback E; Hall SK; Geberhiwot T
    Neuropsychology; 2017 Mar; 31(3):242-254. PubMed ID: 28240926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adult cognitive outcomes in phenylketonuria: explaining causes of variability beyond average Phe levels.
    Romani C; Manti F; Nardecchia F; Valentini F; Fallarino N; Carducci C; De Leo S; MacDonald A; Palermo L; Leuzzi V
    Orphanet J Rare Dis; 2019 Nov; 14(1):273. PubMed ID: 31779649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term cognitive and psychosocial outcomes in adults with phenylketonuria.
    Aitkenhead L; Krishna G; Ellerton C; Moinuddin M; Matcham J; Shiel L; Hossain S; Kiffin M; Foley J; Skeath R; Cleary M; Lachmann R; Murphy E
    J Inherit Metab Dis; 2021 Nov; 44(6):1353-1368. PubMed ID: 34145605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mental health and social functioning in early treated Phenylketonuria: the PKU-COBESO study.
    Jahja R; Huijbregts SC; de Sonneville LM; van der Meere JJ; Bosch AM; Hollak CE; Rubio-Gozalbo ME; Brouwers MC; Hofstede FC; de Vries MC; Janssen MC; van der Ploeg AT; Langendonk JG; van Spronsen FJ
    Mol Genet Metab; 2013; 110 Suppl():S57-61. PubMed ID: 24183792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive profile and mental health in adult phenylketonuria: A PKU-COBESO study.
    Jahja R; Huijbregts SCJ; de Sonneville LMJ; van der Meere JJ; Legemaat AM; Bosch AM; Hollak CEM; Rubio-Gozalbo ME; Brouwers MCGJ; Hofstede FC; de Vries MC; Janssen MCH; van der Ploeg AT; Langendonk JG; van Spronsen FJ
    Neuropsychology; 2017 May; 31(4):437-447. PubMed ID: 28318283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of blood phenylalanine levels on neurocognitive function in adult PKU patients.
    Bartus A; Palasti F; Juhasz E; Kiss E; Simonova E; Sumanszki C; Reismann P
    Metab Brain Dis; 2018 Oct; 33(5):1609-1615. PubMed ID: 29948654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of phenylalanine on cognitive, cerebral, and neurometabolic parameters in adult patients with phenylketonuria (the PICO study): a randomized, placebo-controlled, crossover, noninferiority trial.
    Trepp R; Muri R; Abgottspon S; Bosanska L; Hochuli M; Slotboom J; Rummel C; Kreis R; Everts R
    Trials; 2020 Feb; 21(1):178. PubMed ID: 32054509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurocognitive functioning in adults with phenylketonuria: results of a long term study.
    Weglage J; Fromm J; van Teeffelen-Heithoff A; Möller HE; Koletzko B; Marquardt T; Rutsch F; Feldmann R
    Mol Genet Metab; 2013; 110 Suppl():S44-8. PubMed ID: 24071437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive functions in classic phenylketonuria and mild hyperphenylalaninaemia: experience in a paediatric population.
    Gassió R; Artuch R; Vilaseca MA; Fusté E; Boix C; Sans A; Campistol J
    Dev Med Child Neurol; 2005 Jul; 47(7):443-8. PubMed ID: 15991863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Executive functioning in children and adolescents with phenylketonuria.
    VanZutphen K; Packman W; Sporri L; Needham M; Morgan C; Weisiger K; Packman S
    Clin Genet; 2007 Jul; 72(1):13-8. PubMed ID: 17594394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High phenylalanine levels directly affect mood and sustained attention in adults with phenylketonuria: a randomised, double-blind, placebo-controlled, crossover trial.
    ten Hoedt AE; de Sonneville LM; Francois B; ter Horst NM; Janssen MC; Rubio-Gozalbo ME; Wijburg FA; Hollak CE; Bosch AM
    J Inherit Metab Dis; 2011 Feb; 34(1):165-71. PubMed ID: 21153445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large Neutral Amino Acids (LNAAs) Supplementation Improves Neuropsychological Performances in Adult Patients with Phenylketonuria.
    Scala I; Riccio MP; Marino M; Bravaccio C; Parenti G; Strisciuglio P
    Nutrients; 2020 Apr; 12(4):. PubMed ID: 32326614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive Functioning in Adults with Phenylketonuria in a Cohort of Spanish Patients.
    Luna PM; López-Paz JF; García M; Amayra I; Martínez O; Pérez M; Rodríguez AA; Pérez-Núñez P; Ceberio I; Mansilla N; Soria C
    Behav Neurol; 2023; 2023():9681740. PubMed ID: 36815863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developmental Trajectories of Executive and Verbal Processes in Children with Phenylketonuria.
    Hawks ZW; Strube MJ; Johnson NX; Grange DK; White DA
    Dev Neuropsychol; 2018; 43(3):207-218. PubMed ID: 29432026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variability in phenylalanine control predicts IQ and executive abilities in children with phenylketonuria.
    Hood A; Grange DK; Christ SE; Steiner R; White DA
    Mol Genet Metab; 2014 Apr; 111(4):445-51. PubMed ID: 24568837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.